S. M. Shanehsaz and S. Ishkhanian, “Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients”, J Pak Assoc Dermatol, vol. 23, no. 4, pp. 412–417, Dec. 2016.